Comparison of the susceptibilities of Burkholderia pseudomallei to meropenem and ceftazidime by conventional and intracellular methods

Antimicrobial Agents and Chemotherapy

Volumn 48, Issue 8, 2004, Pages 2999-3005

  Inglis, T J J ^a   Rodrigues, F ^a   Rigby, P ^b   Norton, R ^c   Currie, B J ^d  

^a Western Australian Centre for Pathology and Medical Research   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c TOWNSVILLE HOSPITAL   (Australia)

^d FLINDERS UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CEFTAZIDIME; MEROPENEM;

ACANTHAMOEBA; ARTICLE; AUSTRALIA; BACTERIAL COUNT; BACTERIUM CULTURE; BACTERIUM ISOLATE; BURKHOLDERIA PSEUDOMALLEI; COCULTURE; DRUG SENSITIVITY; MINIMUM INHIBITORY CONCENTRATION; OPTICAL DENSITY; PHAGOCYTE; PRIORITY JOURNAL; TROPHOZOITE;

ACANTHAMOEBA; ANIMALS; BURKHOLDERIA PSEUDOMALLEI; CEFTAZIDIME; CEPHALOSPORINS; DISEASE OUTBREAKS; HUMANS; INDICATOR DILUTION TECHNIQUES; INDICATORS AND REAGENTS; MELIOIDOSIS; MICROBIAL SENSITIVITY TESTS; REPRODUCIBILITY OF RESULTS; THIENAMYCINS; TREATMENT OUTCOME; WESTERN AUSTRALIA;

EID: 3342951848     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.48.8.2999-3005.2004     Document Type: Article

References (15)

1. Chaowagul, W., Y. Suputtamongkol, D. A. Dance, A. Rajchannvong, J. Pattara-arechachai, and N. J. White. 1993. Relapse in melioidosis: incidence and risk factors. J. Infect. Dis. 168:1181-1185.
2. Currie, B. J., D. A. Fisher, D. M. Howard, J. N. C. Burrow, S. Selvanayagam, P. L. Snelling, N. M. Anstey, and M. Mayo. 2000. The epidemiology of melioidosis in Australia and Papua New Guinea. Acta Trop. 74:121-127.
3. Dance, D. A., V. Wuthiekanun, W. Chaowagul, and N. J. White. 1989. The antimicrobial susceptibility of Pseudomonas pseudomallei. Emergence of resistance in vitro and during treatment. J. Antimicrob. Chemother. 24:295-309.
4. Huang, M., P. N. Baker, S. Bannerjee, and F. C. Tenover. 1992. Accuracy of the E test for determining antimicrobial susceptibilities of staphylococci, enterococci, Campylobacter jejuni, and gram-negative bacteria resistant to antimicrobial agents. J. Clin. Microbiol. 30:3243-3248.
5. Inglis, T. J. J., S. C. Garrow, C. Adams, M. Henderson, M. Mayo, and B. J. Currie. 1999. Acute melioidosis outbreak in Western Australia. Epidemiol. Infect. 123:437-444.
6. Inglis, T. J. J., P. Rigby, T. A. Robertson, N. S. Dutton, M. Henderson, and B. J. Chang. 2000. Interaction between Burkholderia pseudomallei and Acanthamoeba species results in coiling phagocytosis, endamebic bacterial survival, and escape. Infect. Immun. 68:1681-1686.
7. Inglis, T. J. J., C. L. Golledge, A. Clair, and J. Harvey. 2001. Case report: recovery from persistent septicemic melioidosis. Am. J. Trop. Med. 65:76-82.
8. Inglis, T. J. J., L. O'Reilly, N. Foster, A. Clair, and J. Sampson. 2002. Comparison of rapid, automated ribotyping and DNA macrorestriction analysis of Burkholderia pseudomallei. J. Clin. Microbiol. 40:3198-3203.
9. Jenney, A. W., G. Lum, D. A. Fisher, and B. J. Currie. 2001. Antibiotic susceptibility of Burkholderia pseudomallei from tropical northern Australia and implications for therapy of melioidosis. Int. J. Antimicrob. Agents. 17:109-113.
10. Jones, A. L., T. J. Beveridge, and D. E. Woods. 1996. Intracellular survival of Burkholderia pseudomallei. Infect. Immun. 64:782-790.
11. National Committee for Clinical Laboratory Standards. 1993. Performance standards for antimicrobial disk susceptibility tests. Approved standard M2-A5. National Committee for Clinical Laboratory Standards, Villanova, Pa.
12. Simpson, A. J., Y. Suputtamongkol, M. D. Smith, B. J. Angus, A. Rajanuwong, V. Wuthiekanun, P. A. Howe, A. L. Walsh, W. Chaowagul, and N. J. White. 1999. Comparison of imipenem and ceftazidime as therapy for severe melioidosis. Clin. Infect. Dis. 29:381-387.
13. Smith, M. D., V. Wuthiekanun, A. L. Walsh, and N. J. White. 1996. In vitro action of carbapenem antibiotics against β-lactamase susceptible and resistant strains of Burkholderiapseudomallei. J. Antimicrob. Chemother. 37:611-615.
14. Ulett, G. C., R. Hirst, B. Bowden, K. Powell, and R. Norton. 2003. A comparison of antibiotic regimens in the treatment of acute melioidosis in a mouse model. J. Antimicrob. Chemother. 51:77-81.
15. White, N. J., D. A. Dance, W. Chaowagul, Y. Wattanagoon, V. Wuthiekanun, and N. Pitakwachara. 1989. Halving of mortality of severe melioidosis by ceftazidime. Lancet ii:697-701.